187 related articles for article (PubMed ID: 30923325)
1. Effects of GADL1 overexpression on cell migration and the associated morphological changes.
Wu TN; Chen CK; Liu IC; Wu LS; Cheng AT
Sci Rep; 2019 Mar; 9(1):5298. PubMed ID: 30923325
[TBL] [Abstract][Full Text] [Related]
2. Variant GADL1 and response to lithium therapy in bipolar I disorder.
Chen CH; Lee CS; Lee MT; Ouyang WC; Chen CC; Chong MY; Wu JY; Tan HK; Lee YC; Chuo LJ; Chiu NY; Tsang HY; Chang TJ; Lung FW; Chiu CH; Chang CH; Chen YS; Hou YM; Chen CC; Lai TJ; Tung CL; Chen CY; Lane HY; Su TP; Feng J; Lin JJ; Chang CJ; Teng PR; Liu CY; Chen CK; Liu IC; Chen JJ; Lu T; Fan CC; Wu CK; Li CF; Wang KH; Wu LS; Peng HL; Chang CP; Lu LS; Chen YT; Cheng AT;
N Engl J Med; 2014 Jan; 370(2):119-28. PubMed ID: 24369049
[TBL] [Abstract][Full Text] [Related]
3. Lithium and GADL1 regulate glycogen synthase kinase-3 activity to modulate KCTD12 expression.
Wu TN; Chen CK; Lee CS; Wu BJ; Sun HJ; Chang CH; Chen CY; Wu LS; Cheng AT
Sci Rep; 2019 Jul; 9(1):10255. PubMed ID: 31311980
[TBL] [Abstract][Full Text] [Related]
4. Lithium response in bipolar disorder: No difference in GADL1 gene expression between cell lines from excellent-responders and non-responders.
Moreira J; Courtin C; Geoffroy PA; Curis E; Bellivier F; Marie-Claire C
Psychiatry Res; 2017 May; 251():217-220. PubMed ID: 28214779
[TBL] [Abstract][Full Text] [Related]
5. Variant GADL1 and response to lithium in bipolar I disorder.
Anghelescu I; Dettling M
N Engl J Med; 2014 May; 370(19):1859. PubMed ID: 24806177
[No Abstract] [Full Text] [Related]
6. Variant GADL1 and response to lithium in bipolar I disorder.
; Hou L; Heilbronner U; Rietschel M; Kato T; Kuo PH; McMahon FJ; Schulze TG
N Engl J Med; 2014 May; 370(19):1857-9. PubMed ID: 24806176
[No Abstract] [Full Text] [Related]
7. Variant GADL1 and response to lithium in bipolar I disorder.
Ikeda M; Kondo K; Iwata N
N Engl J Med; 2014 May; 370(19):1856-7. PubMed ID: 24806175
[No Abstract] [Full Text] [Related]
8. Variant GADL1 and response to lithium in bipolar I disorder.
Vlachadis N; Vrachnis N; Economou E
N Engl J Med; 2014 May; 370(19):1856. PubMed ID: 24806174
[No Abstract] [Full Text] [Related]
9. Variant GADL1 and response to lithium in bipolar I disorder.
Birnbaum R; Shin JH; Weinberger D
N Engl J Med; 2014 May; 370(19):1855-6. PubMed ID: 24806173
[No Abstract] [Full Text] [Related]
10. Variant GADL1 and response to lithium in bipolar I disorder.
Lee CS; Cheng AT
N Engl J Med; 2014 May; 370(19):1859-60. PubMed ID: 24806172
[No Abstract] [Full Text] [Related]
11. No evidence for GADL1 variation as a bipolar disorder susceptibility factor in a Caucasian lithium-responsive cohort.
Cruceanu C; Alda M; Dion PA; Turecki G; Rouleau GA
Am J Psychiatry; 2015 Jan; 172(1):94-5. PubMed ID: 25553497
[No Abstract] [Full Text] [Related]
12. GADL1 gene polymorphisms and lithium response in bipolar I disorder: lack of association from an Indian population.
Kotambail A; Mathur A; Bhat SM; Rai PS; Sharma PS; Satyamoorthy K
Psychiatr Genet; 2015 Feb; 25(1):39-40. PubMed ID: 25415457
[No Abstract] [Full Text] [Related]
13. Immunophenotypes associated with bipolar disorder and lithium treatment.
Wu TN; Lee CS; Wu BJ; Sun HJ; Chang CH; Chen CY; Chen CK; Wu LS; Cheng AT
Sci Rep; 2019 Nov; 9(1):17453. PubMed ID: 31767892
[TBL] [Abstract][Full Text] [Related]
14. Need exists for genetic predictors of lithium response.
Potash JB; Schulze TG
Evid Based Ment Health; 2014 Aug; 17(3):72. PubMed ID: 24841873
[No Abstract] [Full Text] [Related]
15. Mammalian CSAD and GADL1 have distinct biochemical properties and patterns of brain expression.
Winge I; Teigen K; Fossbakk A; Mahootchi E; Kleppe R; Sköldberg F; Kämpe O; Haavik J
Neurochem Int; 2015 Nov; 90():173-84. PubMed ID: 26327310
[TBL] [Abstract][Full Text] [Related]
16.
Chen CK; Lee CS; Chen HY; Wu LS; Chang JC; Liu CY; Cheng AT
BJPsych Open; 2016 Sep; 2(5):301-306. PubMed ID: 27703793
[TBL] [Abstract][Full Text] [Related]
17. Role of glutamate decarboxylase-like protein 1 (GADL1) in taurine biosynthesis.
Liu P; Ge X; Ding H; Jiang H; Christensen BM; Li J
J Biol Chem; 2012 Nov; 287(49):40898-906. PubMed ID: 23038267
[TBL] [Abstract][Full Text] [Related]
18. Lithium response and Val66Met polymorphism of the brain-derived neurotrophic factor gene in Japanese patients with bipolar disorder.
Masui T; Hashimoto R; Kusumi I; Suzuki K; Tanaka T; Nakagawa S; Suzuki T; Iwata N; Ozaki N; Kato T; Kunugi H; Koyama T
Psychiatr Genet; 2006 Apr; 16(2):49-50. PubMed ID: 16538178
[TBL] [Abstract][Full Text] [Related]
19. The effects of lithium and anticonvulsants on brain structure in bipolar disorder.
Germaná C; Kempton MJ; Sarnicola A; Christodoulou T; Haldane M; Hadjulis M; Girardi P; Tatarelli R; Frangou S
Acta Psychiatr Scand; 2010 Dec; 122(6):481-7. PubMed ID: 20560901
[TBL] [Abstract][Full Text] [Related]
20. Glucocorticoid receptor polymorphism is associated with lithium response in bipolar patients.
Szczepankiewicz A; Rybakowski JK; Suwalska A; Hauser J
Neuro Endocrinol Lett; 2011; 32(4):545-51. PubMed ID: 21876507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
